The investigational monoclonal antibody DISC-0974 shows early promise for treating functional iron deficiency in patients with nondialysis CKD and anemia. An anti-hemojuvelin antibody is being ...
Lactoferrin is an effective therapy for children with anemia of CKD. Both oral lactoferrin and intravenous iron dextran can effectively treat anemia of chronic kidney disease (CKD) in children, ...
SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients, highlighting ...
Please provide your email address to receive an email when new articles are posted on . Patients switched to oral vadadustat had hemoglobin levels similar to those on a long-acting ...
WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
The strike, which is expected to disrupt travel plans for more than 100,000 passengers, is the flight attendants' first since 1985.
Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...
Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns ...
Hosted on MSN
Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk
Ozempic, a drug for diabetes and weight loss, continues to be the talk of the town. Recently, the US Food and Drug Administration (FDA) approved Novo Nordisk’s diabetes-cum-weight loss medicine called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback